Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital.
Marta M Valera-RubioMaría Isabel Mi Sierra-TorresRaquel R Castillejo GarcíaJaime J Cordero-RamosMaría Reyes Mr López-MárquezÓscar O Cruz-SalgadoMiguel Ángel Ma Calleja-HernándezPublished in: Expert review of vaccines (2022)
Licensed mRNA vaccines were highly safe when administered under post-marketing conditions among working-age adults. The main adverse events were mild, although they occurred in most patients, especially after the mRNA-1273 vaccine.